Mckeown esophagectomy | |||
---|---|---|---|
Demographics | Open surgery | MIE | P |
Number (n) | 75 | 120 | |
Age (y) | 58.19 ± 7.82 | 56.76 ± 6.48 | 0.088 |
Sex | |||
Female | 10 (13.3) | 26 (21.7) | 0.185 |
Male | 65 (86.7) | 94 (78.3) | |
Pretherapeutic clinical stage | 0.862 | ||
I | 9 (12.0) | 11 (9.2) | |
II | 19 (25.3) | 27 (22.5) | |
III | 29 (38.7) | 50 (41.7) | |
IV | 18 (24.0) | 32 (26.7) | |
Neoadjuvant therapy | < 0.001 | ||
Chemotherapy | 47 (62.7) | 30 (25.0) | |
Chemoradiation | 28 (37.3) | 90 (75.0) | |
Operation date | 0.003 | ||
2010.1–2013.12 | 45 (60.0) | 45 (37.5) | |
2014.1–2016.12 | 30 (40.0) | 75 (62.5) | |
R0 resection | 75 (100.0) | 120 (100.0) | 1.000 |
Location | 0.077 | ||
Upper third | 31 (41.3) | 31 (25.8) | |
Middle third | 29 (38.7) | 59 (49.2) | |
Lower third | 15 (20.0) | 30 (25.0) | |
Total resected LNs | 30.44 ± 15.00 | 23.53 ± 10.15 | < 0.001 |
Postoperative therapy | |||
No | 48 (64.0) | 93 (77.5) | 0.059 |
Yes | 27 (36.0) | 27 (22.5) |